Application

15930933 · BISPECIFIC ANTI-CD3 X CD20 ANTIBODIES AND USES THEREOF

Filed 2020-05-13 · Abandoned The official file ↗ · Art unit 1643 · Examiner Sung Min Yoon Typical · CPC C07K 16/2809 · QLB Biotherapeutics · FINNEGAN, HENDERSON, FARABOW, GARRETT & DUNNER

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

26.4 mo

to disposition 32.8 mo

Statutes raised

0 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.